About Longdom Conferences:

Longdom Conferences hosts 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Surgery and Anaesthesia research, Longdom Meetings is hosting its “2nd International Congress on Virology, Emerging Diseases and Vaccines”. This is scheduled for March 17-18, 2025 in Singapore City, Singapore. The field of Virology, Emerging and Vaccines is one of the oldest scientific subjects, which is continuously evolving and has placed many landmarks in different research and development sectors. These fields are ecological science, agronomy, healthcare, drug discovery, food technology, and many other industrial areas. The Vaccine 2025 extends immense pleasure in inviting you to join us at this conference which will be focusing on the theme “New Innovations in the Field of Vaccines & Immunology”. We aim to engage, empower, evolve, and explore knowledge among attendees from all levels of scientific research on Surgery. This Virology, Emerging and Vaccines conference will focus on the core knowledge and major advances in the rapidly emerging fields by attracting eminent scholars, experts, and professionals globally.

Why join LONGDOM conferences?

Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore

Who will be the participants?

Academic Deans and Directors | Professors and project leads | Postdocs and research scholars | Young scientists and students | CEOs/ CFOs/ Chairs/ Vice-Chairs | Marketing/ business and development teams | Experts who are keen-sighted for collaboration | Product designers and resolution workers | Business sales & services professionals | Associations and society members | Funding organizations & fundraisers

Important Scientific Sessions

Track- 1: Vaccine Safety
Vaccines are very secure. As with all drugs, side effects can occur after getting an immunization. In any case, these are usually very minor and of short duration, such as a sore arm or a mild fever. More serious side effects are possible
Several safeguards are required by law to help ensure that the antibodies we receive are safe. Because antibodies are given to millions of healthy people including children to avoid serious diseases, they’re held to very tall security standards.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 2: Vaccinations for Children
Vaccination given to children is called childhood Immunization. There are several antibodies for infants, new-born, and little children up to 6 for a long time so nowadays vaccination for babies is required unless the child has special circumstances, such as a compromised safety system or a neurological disorder all these precautionary steps are explained briefly in the Vaccine Conference.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track-3: HIV and AIDS Vaccines
Immunization for Aids does not yet exist, but efforts to develop a vaccine against HIV are going on. At display, there are no therapeutic HIV immunizations affirmed by the FDA, the virus that causes Aids, has been underway for many years. CD4 cells are a type of lymphocyte that plays a vital part in the immune system. HIV antibodies would play an effective role in ensuring the end of the Aids epidemic.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 4: Vaccines Research & Development
Antibody Development may be a process that mainly centers on various technological initiatives and applied research, which enhance and promote new systems and practices for vaccine safety. Within the past year, the uncommon Ebola disease outbreak has worldwide research and industry response and as we continue to search for solutions, we must audit the lessons gained to overcome the current problems.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 5: Cancer Vaccines
Cancer is a treatment that uses your body's resistant system to help fight for its curation. Get information about the different types of immunotherapy and the types of cancer they treat. The main types of immunotherapy now being used to treat cancer incorporate
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track-6: Vaccine Necessary
Vaccines are necessary and good hygiene, sanitation, clean water, and nutrition are insufficient for stopping infectious diseases. If we don’t keep up ideal immunization rates or “herd immunity”, the maladies anticipated by immunization will return.
A Conventional antibody comprises specialists that resemble the disease-causing organism. When these agents enter the human body they stimulate the immune system to recognize these agents as remote and destroy them.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 7: Vaccine Production & Development
Immunization advancement is an action that spotlights a collection of mechanical activities and applied research, which overhaul and development made strides in frameworks and practices for antibody wellbeing. In the previous year, the uncommon Ebola disease episode aroused research and industry reaction and as we keep on searching for arrangements, we should overview the exercises learned to conquer the ebb and flow challenges.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 8: Vaccine Safety & Efficacy
Counter-acting agent adequacy implies the capacity of immunizations to achieve the proposed useful consequences for vaccinated people in a characterized populace under perfect states of utilization. The potential advantages of a successful immunization – for illustration progression of well-being and prosperity, and confirmation from affliction and its physical, mental, and monetary outcomes must be weighed against the potential danger of an adversarial occasion taking after vaccination (AEFI) with that immunization.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 9: Vaccines and Development
Each antibody beneath improvement must begin with undergoing screenings and assessments to decide which antigen ought to be utilized to conjure a resistant reaction. This preclinical stage is done without testing on people. A test antibody is, to begin with, tried in creatures to evaluate their security and potential to avoid the malady.
Most vaccines have been in use for decades, with millions of people getting them safely every year. As with all medications, every antibody must go through extensive and rigorous testing to ensure it is safe before it can be introduced in a country’s vaccine program.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 10: Novel Vaccines
Vaccines have led to the global destruction of smallpox, the near global eradication of polio, and amazing reductions in measles infections in most of the developed world, The revelation of vaccinations has provoked the nearby demolition of a couple of basic diseases and has enormously influenced success for a nicely insignificant exertion.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track-11: COVID-19 Vaccines
COVID-19 (coronavirus disease 2019) is a sickness caused by an infection. This virus may be a coronavirus called SARS-CoV-2. In the United States, several antibodies are effective at preventing people from getting seriously ill, being hospitalized, and dying from COVID-19. A few of these antibodies have been affirmed by the U.S. Food and Drug Administration (FDA). Others are being used under Emergency Use Authorization (EUA) from the FDA. All of these vaccines have met the FDA's scientific guidelines for safety, effectiveness, and manufacturing quality needed to back authorization or approval.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 12: Vaccinations during Pregnancy
Vaccinating the mother before, during, and after the pregnancy does not only protect the mother, but it will also protect the baby’s health. A risk to a developing hatchling from vaccination of the mother during pregnancy is theoretical. No proof exists of hazard to the baby from inoculating pregnant ladies with inactivated infection or bacterial antibodies or toxoids. Pregnant moms ought to not take live vaccines, such as the Hepatitis B vaccine, polio vaccine, rabies, and rotavirus antibody.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Track- 13: Veterinary Vaccines
Veterinary antibodies play essential roles in protecting cultivated animals (animals), wild animals, and pets from life-threatening diseases. The vaccines also decrease the need for antibiotics and enable the production of sufficient food creatures for the ever-growing human population. The Global Rinderpest Destruction The program, which involved veterinary vaccination, is one of the biggest achievements in veterinary pharmaceuticals. Usually, the primary creature illness to be killed is universal.
Related Conferences: Viral Epidemiology Summits | Vaccine Development Events | Antiviral Research Conferences | Emerging Diseases Summits | Pandemic Preparedness Events | Virology Conferences | Viral Pathogenesis Meetings | Vaccines Summits | Immunization Strategies Meetings | Infectious Diseases Meetings | Viral Pathogenesis Summits | Pandemic Preparedness Summits | Virology Events |

Market Analysis:
The global vaccines market was valued at $43.2 billion in 2023, and is projected to reach $90.7 billion by 2035, growing at a CAGR of 6.4% from 2024 to 2035. Vaccines are essential tools for preventing infectious diseases and reducing their burden on public health. Government-led immunization programs, public health campaigns, and vaccination initiatives prioritize disease prevention, driving demand for vaccines and sustaining market growth. For instance, according to the World Health Organization (WHO), in January 2023, a total of 64 infectious diseases were reported globally, affecting 235 countries and regions. In addition, WHO estimated that more than 25 million outpatient visits and more than 2 million hospitalizations were attributable to rotavirus infections each year. 

A vaccine is a biological preparation that stimulates the immune system to recognize and protect against specific infectious diseases. It typically contains weakened or inactivated forms of pathogens (such as viruses or bacteria) or their components, which trigger an immune response without causing the disease itself. Vaccines help the body develop immunity to a particular disease by priming the immune system to recognize and fight off the pathogen if encountered in the future, thereby preventing, or reducing the severity of illness. 

Why to Attend/ Sponsor/ Exhibitor:
The 2nd International Conference on Virology, Emerging Diseases, and Vaccines is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products of your company, the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent research on Virology Applications.

Business networking is an avenue for vendors to have network and B2B meetings with “Top Scientists and Colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, Email, Digital, and increasingly social and business networking websites.
Your sponsorship/exhibition will give your organization fantastic exposure to around 150 attendees and offer a unique opportunity to align your brand with this very highly successful, high-profile event.
Virology 2025 will provide a terrific and diverse platform to interact and network with fellow industry colleagues.

Benefits of Attending:

• To foster discussions, share expertise and exchange knowledge and best practices at all levels of the healthcare spectrum
• To encourage collaboration and enhance interactions at a global level
• Meet a range of specialists actively practicing in the field
• Strengthen your profile and position your organization as a key industry figure
• Develop new partnerships and networks with key decision-makers/influencers
• Open doors for your organization to connect and develop strategic relationships in a neutral and relaxed sales environment
• Get access to the targeted audience
• Brand Exposure – Promote your company’s message, products, and services through a national Conference marketing campaign
• First-hand live demonstrations to delegates
• To showcase new healthcare technologies and solutions in an intimate setting focused specifically on microbiology

Targeted Audience:

• Directors, CEO’s of Organizations
• Business Development Managers
• Chief Scientific Officers
• R&D Researchers from Pharma Industries
• Professors, Associate Professors, Assistant Professors
• PhD Scholars
• Association, Association presidents and professionals
• Noble laureates in Health Care and Medicine
• Research Institutes and members
• Manufacturing Companies
• Training Institutes